A vision of the future for personalised healthcare

Earlier this month, a major report was released recommending fundamental changes to the UK National Health Service (NHS).

ctDNA technology in lung cancer: personalised healthcare in action

Personalisation of cancer care, by prescribing drugs that target specific mutations in patients' tumours, is already a reality. For a subset of patients with non-small cell lung cancer (NSCLC) and whose tumours have a mutation in a gene called EGFR, targeted therapies are available.

Technology and innovation – pillars of NHS sustainability

The House of Lords Select Committee’s report The Long-term Sustainability of the NHS and Adult Social Care recommends action to enable necessary ‘transformational change’. This excellent report pulls no punches, and while it would have been easy to shy away from technology to  focus solely on issues that warrant more political and media attention - such as funding, models of care and wo...

How to save the NHS: House of Lords Select Committee proposals

The House of Lords Select Committee on the Long-term Sustainability of the NHS convened in May 2016 has released a report today, the product of a major inquiry including a public consultation and evidence sessions with selected experts (including PHG Foundation Chairman Dr Ron Zimmern). The Long-term Sustainability of the NHS and Adult Social Care sets out their conclusions and recommend...

Circulating tumour DNA technology: the future of cancer management?

Cancer is an increasing burden on the health system and projected incidence figures – that 1 in 2 of us born after 1960 will be diagnosed with some form of cancer – make for gloomy reading. However, a combination of technological leaps and marginal gains have led to greatly improved survival figures for many cancers; with now 80% of patients surviving more than 10 years post diagnosis for ...

Machines that learn healthcare?

Machine learning for beginners: view the full infographic here.

Everyone's a winner? Health, wealth, innovation and the NHS

The recently released Accelerated Access Review (AAR) sets out proposals to ensure that NHS staff and patients can access useful innovations sooner.

Innovation and economising: STPs and NHS Test Beds

The NHS’ Sustainability Transformation Plans (STPs) are local plans, covering 44 ’geographical footprints‘, which aim to improve service quality and develop new models of care; improve health and wellbeing and improve NHS efficiency by 2020-21, as per the NHS Five Year Forward View (FYFV). They are place-based systems of care being developed by local health and social ...

NHS innovation: personalised medicine and the human factor

The NHS Health and Care Innovation Expo 2016 took place in Manchester in the first week of September. Sir Bruce Keogh, National Medical Director for NHS England said in his welcome to delegates: “All countries are grappling with the escalating cost of healthcare coupled with changing public perceptions and expectations. Part of the solution to improving quality of care and me...

Genome editing: promising, but beware the hype

Genome editing - hot or not? View the full infographic here

All patients need faster access to useful medical innovations

A new draft publication from the Accelerated Access Review (AAR) sets out a pathway for the adoption of innovative new products in the NHS in England. Produced by Deloitte for the Office of Life Sciences, Accelerating NHS patient access to medical innovations is aimed particularly at small and medium sized enterprises (SMEs) – which presumably have less scope for attempts to change the NHS...